KYMR
Kymera Therapeutics Inc.
$79.94
+$1.05(+1.33%)
56
Overall
55
Value
60
Tech
55
Quality
Market Cap
$6.43B
Volume
289.61K
52W Range
$28.06 - $103.00
Target Price
$118.27
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M | ||
| Total Revenue | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $80.3M | $173.4M | $208.1M | $244.1M | $308.7M | $388.6M | ||
| Research & Development | $62.1M | $137.0M | $164.2M | $189.1M | $240.2M | $316.6M | ||
| Research Expense | $62.1M | $137.0M | $164.2M | $189.1M | $240.2M | $316.6M | ||
| Selling, General & Administrative | $27.3M | $36.3M | $43.8M | $55.0M | $63.5M | $68.2M | ||
| Selling & Marketing Expenses | $9.1M | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $18.2M | $36.3M | $43.8M | $55.0M | $63.5M | $68.2M | ||
| Salaries & Wages | -- | -- | $35.5M | -- | -- | -- | ||
| Depreciation & Amortization | $1.8M | $2.4M | $3.0M | $3.6M | $7.4M | -- | ||
| Depreciation & Amortization | $1.8M | $2.4M | $3.0M | -- | -- | -- | ||
| Amortization | $716.0K | $906.0K | $1.2M | $1.5M | $1.4M | -- | ||
| Other Operating Expenses | $4.2M | $4.2M | $4.7M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||
| Operating income | $-46.3M | $-100.5M | $-161.3M | $-165.5M | $-261.6M | $-349.4M | ||
| EBITDA | $-43.7M | $-97.6M | $-151.7M | $-143.4M | $-216.5M | $-303.0M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $115.0K | $175.0K | $176.0K | $196.0K | $249.0K | -- | ||
| Net Non-Operating Interest Income/Expense | $-121.0K | $-158.0K | $-6.4M | $18.6M | $37.8M | -- | ||
| Other Income/Expense | $-711.0K | $-313.0K | $-6.4M | $-18.6M | $-32.9M | $-34.2M | ||
| Other Special Charges | $711.0K | $313.0K | $6.4M | $18.6M | $37.8M | $38.0M | ||
| SPECIAL ITEMS | ||||||||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | $4.9M | $3.9M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-45.5M | $-100.0M | $-154.6M | $-147.0M | $-223.9M | $-311.4M | ||
| Pre-Tax Income | $-54.6M | $-100.2M | $-154.8M | $-147.0M | $-223.9M | $-311.4M | ||
| NET INCOME | ||||||||
| Net Income | $-45.6M | $-100.2M | $-154.8M | $-147.0M | $-223.9M | $-311.4M | ||
| Net Income (Continuing Operations) | $-45.6M | $-100.2M | $-154.8M | $-147.0M | $-223.9M | $-311.4M | ||
| Net Income (Discontinued Operations) | $-45.6M | $-100.2M | $-154.8M | $-147.0M | $-223.9M | $-311.4M | ||
| Net Income (Common Stockholders) | $-54.6M | $-100.2M | $-154.8M | $-147.0M | $-223.9M | $-311.4M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-304.4M | ||
| TOTALS | ||||||||
| Total Expenses | $80.3M | $173.4M | $208.1M | $244.1M | $308.7M | $388.6M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $17.3M | $48.0M | $53.9M | $58.4M | $75.0M | $84.5M | ||
| Average Shares Outstanding (Diluted) | $17.3M | -- | $53.9M | $58.4M | $75.0M | $84.5M | ||
| Shares Outstanding | $44.8M | $51.7M | $55.2M | $61.1M | $64.9M | $81.6M | ||
| Basic EPS | $-3.15 | $-2.09 | $-2.87 | $-2.52 | $-2.98 | $-3.69 | ||
| Basic EPS (Continuing Operations) | $-3.15 | $-2.09 | $-2.87 | $-2.52 | $-2.98 | $-3.69 | ||
| Diluted EPS | $-3.15 | $-2.09 | $-2.87 | $-2.52 | $-2.98 | $-3.69 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-2.87 | $-2.52 | $-2.98 | $-3.69 | ||
| OTHER METRICS | ||||||||
| Allowances For Construction | $9.1M | -- | -- | -- | -- | -- | ||
| Marketing Expense | $9.1M | -- | -- | -- | -- | -- | ||
| Other Gand A | $18.2M | $36.3M | $43.8M | $55.0M | $63.5M | $68.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $79.94 | +1.3% | 289.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW